By Market Intelligence Team

The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to for its Minuteful Kidney test, a smartphone application that is used to assess a urine sample to detect proteins associated with chronic kidney disease (CKD). The app uses artificial intelligence to assess the standard albumin-to-creatinine ratio (ACR) of a urine sample. ACR is an early indicator of kidney damage. The Minuteful Kidney test can be used with all current iOS and Android smartphone devices. By adopting and covering this technology, health plans can screen consumers at scale to detect members with early-stage kidney disease and treat them…
Content Restricted

You must be a Free or Elite member to view this resource.

Log In | Sign up or learn more about membership options.

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!